Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 12/2015

01-12-2015 | Letter

Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients

Authors: Bastiaan H. Wittekamp, David S. Y. Ong, Olaf L. Cremer, Marc J. M. Bonten

Published in: Intensive Care Medicine | Issue 12/2015

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360:20–31CrossRefPubMed
2.
de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J et al (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016CrossRefPubMed
3.
Ong DS, Klein Klouwenberg PM, Spitoni C, Bonten MJ, Cremer OL (2013) Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study. Crit Care 17:R233PubMedCentralCrossRefPubMed
4.
Eggimann P, Wolff M, Garbino J (2005) Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? Intensive Care Med 31:1466–1468CrossRefPubMed
Metadata
Title
Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients
Authors
Bastiaan H. Wittekamp
David S. Y. Ong
Olaf L. Cremer
Marc J. M. Bonten
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 12/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4081-x

Other articles of this Issue 12/2015

Intensive Care Medicine 12/2015 Go to the issue

Letter

Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients

What's New in Intensive Care

What’s new in vasopressin?

Original

Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU

Seven-Day Profile Publication

Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study

Original

Benzodiazepine-associated delirium in critically ill adults

Correspondence

Look before leaping into combining extracorporeal techniques to improve oxygenation!